Humana
HUM
396.51
-7.76
-1.92%
Humana
US · HUM
#477 by market cap
Listed 1970
396.51
-7.76
-1.92%
Live - 5344 symbols - heartbeat 263s ago
· 2026-10-08 07:07
Pre-market
400.70
+1.06%
After-hours
400.00
+0.88%
- Market cap
- 47.61B
- P/E (TTM)i
- 37.48
- P/Bi
- 2.48
- EPSi
- 9.84
- Div yieldi
- 0.89%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on HUM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 101.21% +0.16pp
- Institutions
- 1,133 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund80.34%
Hedge Fund10.62%
Public Company4.43%
Private Company1.87%
Government Pension Fund1.63%
Sovereign Wealth Fund1.54%
Insurance Company0.32%
VC/PE Fund0.14%
Government0.11%
Top holders as of 2026-06-30
Dodge & Cox
9.11% · 10.94M sh
BlackRock
8.68% · 10.42M sh
Vanguard Capital Management, LLC
7.09% · 8.52M sh
Vanguard Portfolio Management, LLC
4.85% · 5.82M sh
State Street Global Advisors
4.54% · 5.46M sh
Capital Research
3.80% · 4.57M sh
Pzena Investment Management, Inc.
3.67% · 4.40M sh
Eagle Capital Management LLC
3.20% · 3.85M sh
Sessa Capital IM, L.P.
3.10% · 3.73M sh
MFS Investment Management
2.98% · 3.58M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 37 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| Frank D'Amelio | Independent Director | 0.02% |
| Kurt Hilzinger | Independent Chairperson | 0.02% |
| James Rechtin | President | 0.01% |
| Vishal Agrawal | Chief Strategy & Corporate Development Officer | 0.01% |
| Joseph Ventura | Chief Legal Officer | 0.01% |
| Susan Diamond | Chief Financial Officer | 0.01% |
| George Renaudin | President of Medicare & Medicaid | 0.01% |
| David Dintenfass | President of Enterprise Growth | 0.01% |
| Celeste Mellet | Chief Financial Officer | 0.00% |
| Jorge Mesquita | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Kurt Hilzinger | Independent Chairperson | Other Derivative Acquisition | +238 | -- |
| 2026-08-30 | Shantanu Nundy | Chief Medical Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-07-31 | Frederick John Crawford | Independent Director | Other Acquisition | +544 | -- |
| 2026-07-31 | Paul Smith | Independent Director | Other Acquisition | +544 | -- |
| 2026-07-27 | Frederick John Crawford | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-27 | Paul Smith | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-29 | Kurt Hilzinger | Independent Chairperson | Other Derivative Acquisition | +233 | -- |
| 2026-04-30 | Joseph Ventura | Chief Legal Officer | Other Acquisition | +10,318 | -- |
| 2026-04-30 | Sanjay Shetty | President of Health Care Services Business | Other Acquisition | +9,945 | -- |
| 2026-04-30 | Celeste Mellet | Chief Financial Officer | Other Acquisition | +15,387 | -- |
| 2026-04-30 | James Rechtin | President | Other Acquisition | +35,633 | -- |
| 2026-04-30 | Michelle O’Hara | Chief Human Resources Officer | Other Acquisition | +10,485 | -- |
| 2026-04-30 | David Dintenfass | President of Enterprise Growth | Other Acquisition | +11,273 | -- |
| 2026-04-30 | Japan Mehta | Chief Information Officer | Other Acquisition | +9,448 | -- |
| 2026-04-30 | Aaron Martin | President of Medicare Advantage | Other Acquisition | +8,206 | -- |
| 2026-04-30 | Robert Field | Director | Other Acquisition | +852 | -- |
| 2026-04-15 | Robert Field | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-31 | Sanjay Shetty | President of Health Care Services Business | Derivative Exercise and Sale | -401 | $175.44 |
| 2026-03-31 | Sanjay Shetty | President of Health Care Services Business | Derivative Exercise and Retained | +486 | -- |
| 2026-03-30 | Kurt Hilzinger | Independent Chairperson | Other Derivative Acquisition | +536 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:07:15 · For reference only, not investment advice and not tailored to your situation.